Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment

Acta Biomaterialia

Volumn 21, Issue , 2015, Pages 85-98

  Xu, Gaofei ^a,b   Shi, Changying ^a   Guo, Dandan ^a   Wang, Lili ^a   Ling, Yun ^b   Han, Xiaobing ^a   Luo, Juntao ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Drug delivery; Irinotecan; Micelles; Nanomedicine; SN 38

Indexed keywords

CONTROLLED DRUG DELIVERY; CYTOTOXICITY; DISEASES; DYNAMIC LIGHT SCATTERING; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INFRARED DEVICES; MEDICAL NANOTECHNOLOGY; MICELLES; SOLUTIONS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; TUMORS;

10-HYDROXY-CAMPTOTHECIN; ANTI-CANCER AGENTS; COLON CANCER; DYNAMIC LIGHT-SCATTERING; IRINOTECAN; NANOCARRIERS; NANOFORMULATION; SELF-ASSEMBLE; SN-38; SYNTHESISED;

NANOPARTICLES;

CARBOXYLIC ACID DERIVATIVE; COUMARIN DERIVATIVE; FIRTECAN; IRINOTECAN; NANOCARRIER; TELODENDRIMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; COUMARIN; DENDRIMER; DRUG CARRIER; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CELL LINE; CANCER CHEMOTHERAPY; CHEMICAL COMPOSITION; COLON CANCER; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CROSS LINKING; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; LIGHT SCATTERING; MICELLE; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COLONIC NEOPLASMS; HUMAN; MOLECULAR DYNAMICS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; COUMARINS; DENDRIMERS; DRUG CARRIERS; HUMANS; MOLECULAR DYNAMICS SIMULATION; NANOSTRUCTURES;

EID: 84929948292     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.04.021     Document Type: Article

References (45)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
3. J.F. Pizzolato, and L.B. Saltz The camptothecins Lancet 361 2003 2235 2242
4. D. Cunningham, S. Pyrhonen, R.D. James, C.J. Punt, T.F. Hickish, and R. Heikkila Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 1998 1413 1418
5. L.B. Saltz, J.V. Cox, C. Blanke, L.S. Rosen, L. Fehrenbacher, and M.J. Moore Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 2000 905 914
6. K. Noda, Y. Nishiwaki, M. Kawahara, S. Negoro, T. Sugiura, and A. Yokoyama Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer N Engl J Med 346 2002 85 91
7. S. Negoro, N. Masuda, Y. Takada, T. Sugiura, S. Kudoh, and N. Katakami Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer Br J Cancer 88 2003 335 341
8. D.C. Bodurka, C. Levenback, J.K. Wolf, J. Gano, J.T. Wharton, and J.J. Kavanagh Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer J Clin Oncol 21 2003 291 297
9. P.D. Senter, K.S. Beam, B. Mixan, and A.F. Wahl Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug Bioconjug Chem 12 2001 1074 1080
10. O. Combes, J. Barre, J.C. Duche, L. Vernillet, Y. Archimbaud, and M.P. Marietta In vitro binding and partitioning of irinotecan (CPT-11) and its metabolite, SN-38, in human blood Invest New Drugs 18 2000 1 5
11. H. Bleiberg CPT-11 in gastrointestinal cancer Eur J Cancer 35 1999 371 379
12. V. Bala, S. Rao, B.J. Boyd, and C.A. Prestidge Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38 J Control Release 172 2013 48 61
13. R. Duncan Polymer therapeutics as nanomedicines: new perspectives Curr Opin Biotechnol 22 2011 492 501
14. H. Zhang, J. Wang, W. Mao, J. Huang, X. Wu, and Y. Shen Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies J Control Release 166 2013 147 158
15. P. Sapra, H. Zhao, M. Mehlig, J. Malaby, P. Kraft, and C. Longley Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model Clin Cancer Res 14 2008 1888 1896
16. A. Pal, S. Khan, Y.F. Wang, N. Kamath, A.K. Sarkar, and A. Ahmad Preclinical safety, pharmacokinetics and antitumor efficacy profile of liposome-entrapped SN-38 formulation Anticancer Res 25 2005 331 341
17. N. Vijayalakshmi, A. Ray, A. Malugin, and H. Ghandehari Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation Bioconjug Chem 21 2010 1804 1810
18. Y. Matsumura Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect Adv Drug Deliv Rev 63 2011 184 192
19. K.K. Vangara, J.L. Liu, and S. Palakurthi Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer Anticancer Res 33 2013 2425 2434
20. F. Koizumi, M. Kitagawa, T. Negishi, T. Onda, S. Matsumoto, and T. Hamaguchi Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors Cancer Res 66 2006 10048 10056
21. Hamaguchi T, 2010, Doi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y Hamaguchi, T. Doi, T. Eguchi-Nakajima, K. Kato, Y. Yamada, and Y. Shimada Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors Clin Cancer Res 16 2010 5058 5066
22. U. Kedar, P. Phutane, S. Shidhaye, and V. Kadam Advances in polymeric micelles for drug delivery and tumor targeting Nanomedicine 6 2010 714 729
23. C. Oerlemans, W. Bult, M. Bos, G. Storm, J.F. Nijsen, and W.E. Hennink Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharm Res 27 2010 2569 2589
24. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J Control Release 70 2001 1 20
25. M. Yokoyama Polymeric micelles as a new drug carrier system and their required considerations for clinical trials Expert Opin Drug Deliv 7 2010 145 158
26. A.K. Iyer, K. Greish, T. Seki, S. Okazaki, J. Fang, and K. Takeshita Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation J Drug Target 15 2007 496 506
27. W.P. Caron, G. Song, P. Kumar, S. Rawal, and W.C. Zamboni Interpatient pharmacokinetic and pharmacodynamic variability of carrier-mediated anticancer agents Clin Pharmacol Ther 91 2012 802 812
28. A. Carie, J. Rios-Doria, T. Costich, B. Burke, R. Slama, and H. Skaff IT-141, a Polymer Micelle Encapsulating SN-38, Induces Tumor Regression in Multiple Colorectal Cancer Models J Drug Deliv 2011 2011 869027
29. J. Luo, K. Xiao, Y. Li, J.S. Lee, L. Shi, and Y.H. Tan Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment Bioconjug Chem 21 2010 1216 1224
30. W. Huang, C. Shi, Y. Shao, K.S. Lam, and J. Luo The core-inversible micelles for hydrophilic drug delivery Chem Commun 49 2013 6674 6676
31. K. Xiao, J. Luo, W.L. Fowler, Y. Li, J.S. Lee, and L. Xing A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer Biomaterials 30 2009 6006 6016
32. Y. Li, W. Xiao, K. Xiao, L. Berti, J. Luo, and H.P. Tseng Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols Angew Chem Int Ed Engl 51 2012 2864 2869
33. H.G. Baek, R. Liu, and K.S. Lam Development of hydrogel TentaGel shell-core beads for ultrahigh throughput solution-phase screening of encoded OBOC combinatorial small molecule libraries J Comb Chem 11 2009 91 102
34. J. He, Y. Zhao, and Y. Zhao Photoinduced bending of a coumarin-containing supramolecular polymer Soft Matter 5 2009 308 310
35. Bowers KJ, Chow E, Huageng X, Dror RO, Eastwood MP, Gregersen BA, et al. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. SC 2006 Conference, In: Proceedings of the ACM/IEEE2006. p. 43-.
36. Y. Shan, E.T. Kim, M.P. Eastwood, R.O. Dror, M.A. Seeliger, and D.E. Shaw How does a drug molecule find its target binding site? J Am Chem Soc 133 2011 9181 9183
37. H.J.C. Berendsen, J.P.M. Postma, W.F. van Gunsteren, and J. Hermans Interaction models for water in relation to protein hydration B. Pullman, Intermolecular forces 1981 Springer Netherlands 331 342
38. U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen A smooth particle mesh Ewald method J Chem Phys 103 1995 8577 8593
39. J. Jiang, B. Qi, M. Lepage, and Y. Zhao Polymer micelles stabilization on demand through reversible photo-cross-linking Macromolecules 40 2007 790 792
40. Y. Shao, C. Shi, G. Xu, D. Guo, and J. Luo Photo and redox dual responsive reversibly cross-linked nanocarrier for efficient tumor-targeted drug delivery ACS Appl Mater Interfaces 6 2014 10381 10392
41. J.N. Israelachvili Intermolecular and surfaces forces 2nd ed. 1992 Academic Press London
42. J.F. Gohy, and Y. Zhao Photo-responsive block copolymer micelles: design and behavior Chem Soc Rev 42 2013 7117 7129
43. K.K. Vangara, H.I. Ali, D. Lu, J.L. Liu, S. Kolluru, and S. Palakurthi SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer AAPS PharmSciTech 15 2014 472 482
44. G. Bastiat, C.O. Pritz, C. Roider, F. Fouchet, E. Lignieres, and A. Jesacher A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging J Control Release 170 2013 334 342
45. Y. Zhang, M. Huo, J. Zhou, S. Xie, and P.K. Xie PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Comput Methods Prog Biomed 99 2010 306 314